High-throughput, sensitive and quantitative assay for the detection of BCR-ABL kinase domain mutations

作者: A Vivante , N Amariglio , M Koren-Michowitz , O Ashur-Fabian , A Nagler

DOI: 10.1038/SJ.LEU.2404635

关键词:

摘要:

参考文章(6)
Charles L. Sawyers, Chronic Myeloid Leukemia New England Journal of Medicine. ,vol. 340, pp. 1330- 1340 ,(1999) , 10.1056/NEJM199904293401706
Hagop Kantarjian, Charles Sawyers, Andreas Hochhaus, Francois Guilhot, Charles Schiffer, Carlo Gambacorti-Passerini, Dietger Niederwieser, Debra Resta, Renaud Capdeville, Ulrike Zoellner, Moshe Talpaz, Brian Druker, None, Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia The New England Journal of Medicine. ,vol. 346, pp. 645- 652 ,(2002) , 10.1056/NEJMOA011573
A Hochhaus, S Kreil, AS Corbin, P La Rosée, MC Müller, T Lahaye, B Hanfstein, C Schoch, NCP Cross, U Berger, H Gschaidmeier, BJ Druker, R Hehlmann, Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy. Leukemia. ,vol. 16, pp. 2190- 2196 ,(2002) , 10.1038/SJ.LEU.2402741
Neil P. Shah, Loss of response to imatinib: mechanisms and management. Hematology. ,vol. 2005, pp. 183- 187 ,(2005) , 10.1182/ASHEDUCATION-2005.1.183
Simona Soverini, Giovanni Martinelli, Marilina Amabile, Angela Poerio, Michele Bianchini, Gianantonio Rosti, Fabrizio Pane, Giuseppe Saglio, Michele Baccarani, , , Denaturing-HPLC-Based Assay for Detection of ABL Mutations in Chronic Myeloid Leukemia Patients Resistant to Imatinib Clinical Chemistry. ,vol. 50, pp. 1205- 1213 ,(2004) , 10.1373/CLINCHEM.2004.031112
Timothy Hughes, Michael Deininger, Andreas Hochhaus, Susan Branford, Jerald Radich, Jaspal Kaeda, Michele Baccarani, Jorge Cortes, Nicholas CP Cross, Brian J Druker, Jean Gabert, David Grimwade, Rüdiger Hehlmann, Suzanne Kamel-Reid, Jeffrey H Lipton, Janina Longtine, Giovanni Martinelli, Giuseppe Saglio, Simona Soverini, Wendy Stock, John M Goldman, Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results Blood. ,vol. 108, pp. 28- 37 ,(2006) , 10.1182/BLOOD-2006-01-0092